Evidence map›Paper›PMID 24693316›Full record

ArticleHepatitis monthly2014

GB Virus C infection in Patients With HIV/Hepatitis C Virus Coinfection: Improvement of the Liver Function in Chronic Hepatitis C.

Yue Feng, Li Liu, Yue-Mei Feng, Wenhua Zhao, Zheng Li, A-Mei Zhang, Yuzhu Song, Xueshan Xia

Open access · hybridAbstract read
In one paragraph

Article in Hepatitis monthly, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yue FengFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Li LiuFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Yue-Mei FengResearch Institute of Nutrition and Food Sciences, Kunming Medical University, Kunming, China.
Wenhua ZhaoThe Key Laboratory of Tropical and Subtropical Animal Disease, Kunming, China.
Zheng LiDepartment of Clinical Laboratory, The First People's Hospital of Yunnan Province, Kunming, China.
A-Mei ZhangFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Yuzhu SongFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Xueshan XiaFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
Kunming University of Science and Technology · CNFirst People's Hospital of Yunnan Province · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies in patients with hepatitis C virus (HCV)/HIV coinfection have shown that the presence of GBV-C is associated with significantly less compensated and decompensated cirrhosis, and an improvement in cirrhosis-free survival.

objectivesThis study aimed to describe the effect of GBV-C in patients with chronic hepatitis C and HIV coinfection. PATIENTS AND

methodsWe retrospectively studied 105 injecting drug users with chronic hepatitis C and HIV coinfection and 72 patients with chronic HCV mono-infections. Plasma samples were tested for GBV-C RNA with primers to the 5'untranslated region gene. HIV and HCV viral load, CD4(+) and CD8(+) cell count, and the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were tested in all patients.

resultsGBV-C RNA was identified in 34 (32.38%) of the patients with HIV/HCV coinfection, and in 24 (33.33%) of the patients with HCV mono-infection. GBV-C infection was associated with significantly lower ALT and AST levels in patients with chronic hepatitis C and HIV coinfection, but not in those HCV mono-infections. The presence of GBV-C infection was not correlated with CD4(+) and CD8(+) cell count, gender, age, HIV load, HCV load, and HCV genotype.

conclusionsThis study found that GBV-C infection has a high frequency among injecting drug users with HIV/HCV coinfection and HCV mono-infection in Yunnan, China. In patients with chronic hepatitis C and HIV coinfection, GBV-C RNA was associated with significantly lower ALT and AST levels, suggesting a beneficial effect of GBV-C infection on chronic hepatitis C.

Indexed as

CoinfectionGB virus CHepatitis C virusHIVLiver Function Tests

Identifiers

PMID24693316
PMCPMC3955267
OpenAlexW2131894567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.